Reich Kristian (CIK 1920553) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-17). Recent activity: Sell MLTX (50,000 shares), Sell MLTX (50,000 shares), Sell MLTX (50,000 shares), Buy MLTX (35,389 shares), Sell MLTX (35,389 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | MoonLake Immunotherapeutics (MLTX) | Chief Scientific Officer | Sell | 50,000 | $944,500 |
| 2026-06-17 | MoonLake Immunotherapeutics (MLTX) | Chief Scientific Officer | Sell | 50,000 | $935,000 |
| 2026-06-17 | MoonLake Immunotherapeutics (MLTX) | Chief Scientific Officer | Sell | 50,000 | $971,500 |
| 2025-12-22 | MoonLake Immunotherapeutics (MLTX) | Chief Scientific Officer | Buy | 35,389 | $0 |
| 2025-12-22 | MoonLake Immunotherapeutics (MLTX) | Chief Scientific Officer | Sell | 35,389 | $0 |
| 2025-12-10 | MoonLake Immunotherapeutics (MLTX) | Chief Scientific Officer | Sell | 130,000 | $2.0M |
| 2025-12-10 | MoonLake Immunotherapeutics (MLTX) | Chief Scientific Officer | Sell | 72,908 | $1.1M |
| 2025-09-04 | MoonLake Immunotherapeutics (MLTX) | Chief Scientific Officer | Buy | 48,978 | $0 |
| 2025-09-04 | MoonLake Immunotherapeutics (MLTX) | Chief Scientific Officer | Sell | 48,978 | $0 |
| 2025-01-22 | MoonLake Immunotherapeutics (MLTX) | Chief Scientific Officer | Buy | 111,949 | $0 |
| 2025-01-22 | MoonLake Immunotherapeutics (MLTX) | Chief Scientific Officer | Sell | 111,949 | $0 |
Source: SEC Form 4 filings · as of 2026-06-17